5 Key Takeaways

• 1

  Trachomatous trichiasis poses significant challenges for public health, with high relapse rates undermining surgical outcomes.

• 2

  The FLAME trial tested fluorometholone 0.1% eye drops as adjunctive therapy after trachomatous trichiasis surgery in Ethiopia.

• 3

  The trial enrolled 2,410 participants, with a high follow-up rate of approximately 98% at 12 months.

• 4

  Results showed no difference in postoperative trachomatous trichiasis incidence between the fluorometholone and placebo groups.

• 5

  Fluorometholone is safe but does not reduce relapse rates, indicating a need for improved surgical techniques and training.